Full metadata record
DC FieldValueLanguage
dc.contributor.authorSEMPKOWSKI Michelleen_GB
dc.contributor.authorZHU Charlesen_GB
dc.contributor.authorMENZENSKI Monikaen_GB
dc.contributor.authorKEVREKIDIS Ioannis G.en_GB
dc.contributor.authorBRUCHERTSEIFER Franken_GB
dc.contributor.authorMORGENSTERN Alfreden_GB
dc.contributor.authorSOFOU Stavroulaen_GB
dc.date.accessioned2016-11-24T01:15:43Z-
dc.date.available2016-11-22en_GB
dc.date.available2016-11-24T01:15:43Z-
dc.date.created2016-09-12en_GB
dc.date.issued2016en_GB
dc.date.submitted2015-12-15en_GB
dc.identifier.citationMOLECULAR CANCER THERAPEUTICS vol. 32 no. 33 p. 8329-8338en_GB
dc.identifier.issn1535-7163en_GB
dc.identifier.urihttp://publications.jrc.ec.europa.eu/repository/handle/JRC99551-
dc.description.abstractEffective targeting by uniformly functionalized nanoparticles is limited to cancer cells expressing at least two copies of targeted receptors per nanoparticle footprint (approximately ≥2 × 105 receptor copies per cell); such a receptor density supports the required multivalent interaction between the neighboring receptors and the ligands from a single nanoparticle. To enable selective targeting below this receptor density, ligands on the surface of lipid vesicles were displayed in clusters that were designed to form at the acidic pH of the tumor interstitium. Vesicles with clustered HER2-targeting peptides within such sticky patches (sticky vesicles) were compared to uniformly functionalized vesicles. On HER2-negative breast cancer cells MDA-MB-231 and MCF7 {expressing (8.3 ± 0.8) × 104 and (5.4 ± 0.9) × 104 HER2 copies per cell, respectively}, only the sticky vesicles exhibited detectable specific targeting (KD ≈ 49–69 nM); dissociation (0.005–0.009 min–1) and endocytosis rates (0.024–0.026 min–1) were independent of HER2 expression for these cells. MDA-MB-231 and MCF7 were killed only by sticky vesicles encapsulating doxorubicin (32–40% viability) or α-particle emitter 225Ac (39–58% viability) and were not affected by uniformly functionalized vesicles (>80% viability). Toxicities on cardiomyocytes and normal breast cells (expressing HER2 at considerably lower but not insignificant levels) were not observed, suggesting the potential of tunable clustered ligand display for the selective killing of cancer cells with low receptor densities.en_GB
dc.description.sponsorshipJRC.G.I.5-Advanced Nuclear Knowledgeen_GB
dc.format.mediumPrinteden_GB
dc.languageENGen_GB
dc.publisherAMER ASSOC CANCER RESEARCHen_GB
dc.relation.ispartofseriesJRC99551en_GB
dc.titleSticky Patches on Lipid Nanoparticles Enable the Selective Targeting and Killing of Untargetable Cancer Cellsen_GB
dc.typeArticles in periodicals and booksen_GB
dc.identifier.doi10.1021/acs.langmuir.6b01464en_GB
JRC Directorate:Nuclear Safety and Security

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.